2019M&A Transaction Multiples
Pharmacy Multiples - 2019
Sourced from 16 publicly disclosed Pharmacy acquisitions in 2019. Public records only (SEC EDGAR + verified press releases).
EV / EBITDA
14.3x
median · p25 12.1x - p75 21.2x · n=7
EV / Revenue
0.3x
median · p25 0.2x - p75 6.0x · n=13
Value your Pharmacy business
Instant valuation range + a sellability score with the 5 specific drivers worth the most at the LOI table. Backed by 25,592 real M&A transactions.
Pharmacy multiples by year
Other verticals - 2019 multiples
Aerospace· 18.62x EBITDAApparel· 5.87x EBITDAConsumer Products· 16.08x EBITDADurable Medical Equipment· 6.45x EBITDAElectronics· 14.5x EBITDAFood Manufacturing· 9.29x EBITDAHealthcare IT· 17.05x EBITDAIndustrial Equipment· 10.8x EBITDAIT Services· 6.49x EBITDAMedical Devices· 13.7x EBITDAMedical Practice Specialty· 10.55x EBITDAMetal Fabrication· 7.54x EBITDAOil Gas Services· 6.33x EBITDAOther· 16.95x EBITDAOther Healthcare· 9.9x EBITDAOther Manufacturing· 9.14x EBITDAOther Personal Services· 9.89x EBITDAOther Professional Services· 11.88x EBITDAOther Technology· 14.35x EBITDASaaS· 19.29x EBITDASoftware Enterprise· 22.88x EBITDASpecialty Contractor· 6.07x EBITDASpecialty Retail· 14.93x EBITDAWholesale Distribution· 8.72x EBITDA
Data sourced from 16 disclosed Pharmacy M&A transactions in 2019. Aggregations: median (p50), p25, p75. Quality gate: n ≥ 10 deals per (vertical x year) cell. Data generated 2026-05-26.Full methodology →